Overview: Hypothyroidism Hashimoto Panel
Introduction: The Hypothyroidism Hashimoto Panel is a diagnostic tool designed to screen for hypothyroidism (Hashimoto's thyroiditis) using serum samples. In India, hypothyroidism affects ~10-15 percent of adults (higher in women and iodine-deficient areas), with Hashimoto's (autoimmune) the leading cause, presenting with fatigue, weight gain, cold intolerance, and goiter. High morbidity from under-testing in rural/low-SES populations, limited thyroid labs, delayed levothyroxine leading to dyslipidemia, infertility, or myxedema coma. Per endocrinology practices aligned with ICMR and Endocrine Society of India guidelines, the test employs immunoassay for TSH, free T4, and anti-TPO over 1-2 days with high accuracy, valuable for confirming autoimmune hypothyroidism. This diagnostic falls under thyroid screening and targets patients with fatigue, weight gain, or goiter, addressing accurate detection to guide levothyroxine replacement and monitoring. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise thyroid assessment and reducing complications. Its serum-based approach ensures reliable hormone/antibody measurement.
Other Names: Hashimoto Pnl.
FDA Status: FDA approved, CLIA certified for endocrinology/immunology, compliant with 2025 standards.
Historical Milestone: Hashimoto's panel standard; in India, used in thyroid clinics.
Purpose: The test assesses 3 parameters including TSH to guide hypothyroidism screening, confirm autoimmune etiology, inform therapy.
Test Parameters: 1. TSH, 2. Free T4, 3. Anti-TPO.
Pretest Condition: Fasting 10-12 hours recommended; patients should report fatigue or weight gain.
Specimen: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on cold intolerance, hair loss, family thyroid history.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of untreated hypothyroidism including coma, benefits of diagnosis, and minimal discomfort from venipuncture.
Procedural Considerations: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis, or pregnancy can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: High TSH/low FT4 + positive anti-TPO confirms Hashimoto's, necessitating specialist input.
Specialist Consultation: Endocrinologists should be consulted for management.
Additional Supporting Tests: Thyroid ultrasound, anti-Tg for confirmation.
Test Limitations: Anti-TPO not always positive; comprehensive approach required.
References: Indian Journal of Endocrinology 2024, Thyroid Studies India 2023.
